Opportunity ID: 316343

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-19-288
Funding Opportunity Title: Limited Competition: NIA Genome Center for Alzheimer’s Disease (U54 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 23, 2019
Last Updated Date: May 23, 2019
Original Closing Date for Applications: Sep 25, 2022
Current Closing Date for Applications: Sep 25, 2022
Archive Date: Oct 31, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Special district governments
Small businesses
State governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) invites applications to continue the operations of the NIA Genome Center for Alzheimer’s Disease (GCAD) to facilitate and support the Alzheimer’s Disease Sequencing Project (ADSP) activities. GCAD will serve as the focal point for all phases of ADSP quality control checking, data harmonization, and meta-analysis. The FOA is intended to support a major component of the full range of analysis for the ADSP. The spectrum of the Center’s activities comprises a multidisciplinary attack on Alzheimer’s Disease (AD) and AD Related Dementias (ADRD) in keeping with NIA’s programmatic needs. The Center will serve as a national resource for the specific purpose of identifying potential avenues for therapeutic approaches and prevention of the disease.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-288.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 316343 Full Announcement-PAR-19-288 -> PAR-19-288-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00251304 Aug 25, 2019 May 24, 2020 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00258928 Aug 25, 2019 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00269617 Aug 25, 2019 Sep 25, 2022 View

Package 1

Mandatory forms

316343 RR_SF424_2_0-2.0.pdf

316343 PHS398_CoverPageSupplement_4_0-4.0.pdf

316343 RR_OtherProjectInfo_1_4-1.4.pdf

316343 PerformanceSite_2_0-2.0.pdf

316343 RR_KeyPersonExpanded_2_0-2.0.pdf

316343 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

316343 PHS_Additional_IndirectCosts-1.0.pdf

316343 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

316343 RR_SF424_2_0-2.0.pdf

316343 PHS398_CoverPageSupplement_5_0-5.0.pdf

316343 RR_OtherProjectInfo_1_4-1.4.pdf

316343 PerformanceSite_2_0-2.0.pdf

316343 RR_KeyPersonExpanded_2_0-2.0.pdf

316343 PHS398_ResearchPlan_4_0-4.0.pdf

316343 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

316343 PHS_Additional_IndirectCosts-1.0.pdf

316343 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

316343 RR_SF424_5_0-5.0.pdf

316343 PHS398_CoverPageSupplement_5_0-5.0.pdf

316343 RR_OtherProjectInfo_1_4-1.4.pdf

316343 PerformanceSite_4_0-4.0.pdf

316343 RR_KeyPersonExpanded_4_0-4.0.pdf

316343 PHS398_ResearchPlan_4_0-4.0.pdf

316343 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

316343 PHS_Additional_IndirectCosts_2_0-2.0.pdf

316343 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T17:02:01-05:00

Share This Post, Choose Your Platform!

About the Author: